s6y
Company name or ticker
Search
Opus Genetics, Inc.
4
Gagnon Robert E.: Statement of changes in beneficial ownership of securities
Filed
Tuesday, September 8, 2026
Period
Sep 3, 2026
Accession number
0001140361-26-035912
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header